SPDR S&P Biotech ETF $XBI Position Reduced by Sivik Global Healthcare LLC

Sivik Global Healthcare LLC decreased its holdings in SPDR S&P Biotech ETF (NYSEARCA:XBI) by 10.0% during the 4th quarter, according to its most recent disclosure with the SEC. The firm owned 225,000 shares of the exchange traded fund’s stock after selling 25,000 shares during the period. SPDR S&P Biotech ETF makes up about 8.0% of Sivik Global Healthcare LLC’s investment portfolio, making the stock its largest position. Sivik Global Healthcare LLC owned 0.34% of SPDR S&P Biotech ETF worth $27,434,000 as of its most recent SEC filing.

Other hedge funds have also recently bought and sold shares of the company. Compass Wealth Management LLC acquired a new stake in SPDR S&P Biotech ETF in the third quarter valued at approximately $1,167,000. China Universal Asset Management Co. Ltd. lifted its stake in SPDR S&P Biotech ETF by 868.3% in the third quarter. China Universal Asset Management Co. Ltd. now owns 4,919 shares of the exchange traded fund’s stock valued at $493,000 after buying an additional 4,411 shares during the last quarter. Ashton Thomas Private Wealth LLC bought a new stake in SPDR S&P Biotech ETF in the third quarter valued at $417,000. Altfest L J & Co. Inc. lifted its stake in SPDR S&P Biotech ETF by 63.1% in the third quarter. Altfest L J & Co. Inc. now owns 124,921 shares of the exchange traded fund’s stock valued at $12,517,000 after buying an additional 48,326 shares during the last quarter. Finally, Brian Low Financial Group LLC bought a new stake in SPDR S&P Biotech ETF in the third quarter valued at $668,000.

SPDR S&P Biotech ETF Stock Performance

XBI stock opened at $128.85 on Wednesday. The stock has a market capitalization of $7.85 billion, a price-to-earnings ratio of 11.47 and a beta of 0.91. SPDR S&P Biotech ETF has a 1 year low of $66.66 and a 1 year high of $132.09. The stock’s fifty day moving average is $125.02 and its two-hundred day moving average is $119.02.

About SPDR S&P Biotech ETF

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges. The Biotech Index is a modified equal weight index.